Biomatics Capital Partners - aVenture Asset Manager Research
Location
Seattle, WA, US
Founded
2016
Biomatics Capital Partners is a venture firm specializing in healthcare and life sciences investments. The firm focuses on companies at the intersection of genomics and digital data, primarily participating in Series A and Series B rounds, with occasional involvement in Series C funding. Biomatics aims to support transformative science that can drive the evolution of healthcare into a value-based system, leading to lower costs and better patient outcomes.
Notable portfolio companies include Grail, Denali Therapeutics, and Twist Bioscience. The firm's investment philosophy centers on backing breakthrough science that can revolutionize healthcare. Biomatics offers unique value-add services to its portfolio companies, leveraging its deep expertise in genomics and digital data to foster innovation and growth. Key partners and decision-makers at Biomatics bring extensive experience from leading institutions in the healthcare and life sciences sectors.
Biomatics Capital Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages